<?xml version="1.0" encoding="UTF-8"?>
<p id="p0140">Global collaborations and data sharing are critical for rapid development and in-depth knowledge of key viral families and platform vaccine technologies can accelerate product development for new diseases. Ideally promising vaccine or therapeutic candidates are available at the beginning of an epidemic to facilitate evaluation of their efficacy in the field. The WHO works on standardization of human vaccines, including for zoonotic diseases, while the OIE builds technical standards for animal diseases and vaccines, 
 <italic>e.g.</italic> bovine tuberculosis, and promotes awareness and capacity building globally.
</p>
